A novel mouse model of a highly lethal form of acute myeloid leukemia (AML) offers a new tool for scientists working to better understand this disease and research new therapeutic targets. Scientists ...
Fraud and anti-money laundering (AML) capabilities have advanced significantly in recent years. Yet in many institutions the two functions still operate on separate data, systems and incentives, ...
AML 3.0 by IDMERIT is redefining what modern anti money laundering software looks like - faster screening, smarter monitoring ...
Strategic partnership combines FinScan’s real-time data quality and screening technology with Nexus AML’s expert-led ...
Study to Enroll 80 Patients Unlikely to Benefit from Venetoclax/Azacitide (Aza/Ven) Therapy in the US and Europe -- SELLAS’ Predictive ...
Omeros Corporation (NASDAQ: OMER) today announced the successful completion of its initial study in nonhuman primates ...
SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- A demonstrated 100% concordance between biomarker-guided predictions from pre-treatment patient samples and clinical outcomes validates Yatiri Bio’s ...
Scientists at the University of Glasgow developed a bioengineered bone marrow (BM) model that helped them to evaluate potential use of a combined CRISPR-CAR T cell therapy in the treatment of acute ...
CD25 expression has long been recognized as an adverse prognostic marker in acute leukemias including acute myeloid leukemia ...
The human alveolar macrophage-like (AML) model contains many of the critical features of alveolar macrophages found in the lungs, including onion-shaped phagolysosomes (left) and the cell nucleus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results